studies of fenofibrate + bile acid sequestrants demonstrate that these two therapies may have an additive effect in reducing total cholesterol , low-density lipoprotein ( ldl ) cholesterol , very-low-density lipoprotein ( vldl ) cholesterol and triglyceride levels in patients with hyperlipoproteinemia or familial hypercholesterolemia .
C0033228
fenofibrate
C0020476
hyperlipoproteinemia